Difluoropyrrolidines as orexin receptor modulators
US10221170B2 · kind B2 · utility
6Cited by
2References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 2015 |
| Grant date | Mar 5, 2019 |
| Priority date | — |
| Expiry date | Aug 14, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to certain difluoropyrrolidine compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating substance addiction, panic disorder, anxiety, post-traumatic stress disorder, pain, depression, seasonal affective disorder, an eating disorder, or hypertension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.